The Importance of CNS Activity in Agents for NSCLC

October 20, 2017
Alexander Drilon, MD

Alexander Drilon, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the importance of central nervous system (CNS) activity in agents for the treatment of non–small cell lung cancer (NSCLC).